Autism spectrum disorders and health care expenditures: The effects of co-occurring conditions

Journal of Developmental and Behavioral Pediatrics

Volumn 33, Issue 1, 2012, Pages 2-8

  Peacock, Georgina ^a   Amendah, Djesika ^a,b   Ouyang, Lijing ^a   Grosse, Scott D ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b AFRICAN POPULATION AND HEALTH RESEARCH CENTER   (Kenya)

Author keywords

autism spectrum disorder; cost; expenditures; health care use; hyperkinetic syndrome; ID; Medicaid; seizures

Indexed keywords

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CHILD; CLASSIFICATION; COMORBIDITY; COMPARATIVE STUDY; ECONOMICS; EPILEPSY; FEMALE; HEALTH CARE COST; HUMAN; INFANT; INTELLECTUAL IMPAIRMENT; MALE; MEDICAID; PRESCHOOL CHILD; REGISTER; UNITED STATES;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; COMORBIDITY; EPILEPSY; FEMALE; HEALTH EXPENDITURES; HUMANS; INFANT; INTELLECTUAL DISABILITY; MALE; MEDICAID; REGISTRIES; UNITED STATES;

EID: 84855431804     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/DBP.0b013e31823969de     Document Type: Article

References (10)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 2000.
2. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators, Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009;58:1-20.
3. Levy SE, Giarelli E, Lee LC, et al. Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States. J Dev Behav Pediatr. 2010;31:267-275.
4. Amendah D, Grosse SD, Peacock G, Mandell DS. The economic costs of autism: A review. In: Amaral DG, Dawson G, Geschwind DH, eds. Autism Spectrum Disorders. New York: Oxford University Press; 2011:1343-1358.
5. Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer. 2009;53: 642-646.
6. Leslie DL, Martin A. Health care expenditures associated with autism spectrum disorders. Arch Pediatr Adolesc Med. 2007;161:350-355. (Pubitemid 46556365)
7. Shimabukuro TT, Grosse SD, Rice C. Medical expenditures for children with an autism spectrum disorder in a privately insured population. J Autism Dev Disord. 2008;38:546-552. (Pubitemid 351322378)
8. Croen LA, Najjar DV, Ray T, Lotspeich L, Bernal P. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics. 2006;118:e1203-e1211. (Pubitemid 46393771)
9. Flanders SC, Engelhart L, Pandina GJ, McCracken JT. Direct health care costs for children with pervasive developmental disorders: 1996-2002. Adm Policy Ment Health. 2007;34:213-220. (Pubitemid 46742600)
10. Mandell DS, Cao J, Ittenbach R, Pinto-Martin J. Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999. J Autism Dev Disord. 2006;36:475-485. (Pubitemid 43854344)